⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 25, 2023CirculationOpen Access

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

Milton Packer Javed Butler Cordula Zeller Stuart Pocock Martina Brueckmann João Pedro Ferreira Gerasimos Filippatos Muhammad Usman Faı̈ez Zannad Stefan D. Anker

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

gov; Unique identifiers: NCT03057977 and NCT03057951.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Packer et al. (2023) studied this question.

synapsesocial.com/papers/69dcca985f911386753597fb https://doi.org/10.1161/circulationaha.123.065748

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsRCT · 2022 · 988 citations
2Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolOriginal Research · 1981 · 331 citations
3Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failureother · 1987 · 361 citations
4Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart Failurecase_series · 1982 · 101 citations
5Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failurecohort · 2008 · 256 citations

More related papers

Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction2017
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure1997
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial2018

More from Circulation

Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid ValvesSat,
Multimodal KCNQ1 Variant-Effect Maps Define Ion Channel Mechanisms and Disease RiskTue,